InnerVision’s announcement comes soon after the American Medical Association’s (AMA) official classification of obesity as a disease, requiring a range of medical interventions to advance obesity treatment and prevention.
According to leading industry analyst
“We are thrilled with the early results from our clinical evaluations, specifically within the morbidly obese population,” said
“For our early clinical evaluations, comparative ultrasound exams were performed on subjects with BMIs ranging from 50 to 66 using our system and an industry-leading system,” continued Dr. Ramamurthy. “Initial results show that the InnerVision Medical system consistently delivered a more uniform image with better resolution at depth, providing definitive, diagnostic information on deep structures, such as the liver and kidney. For one subject (BMI 57.5), a physician commented specifically that the industry-leading system’s images of the subject’s liver and kidney were non-diagnostic; however, the InnerVision Medical images were clearly diagnostic.”
Obesity increases the risk of a number of health conditions including hypertension (high blood pressure), type 2 diabetes, gallstones, high cholesterol, coronary artery disease (CAD), sleep apnea and cancer. Obese individuals have a 50-100 percent increased risk of premature death, and it’s estimated that obesity may be the cause of 300,000 deaths per year according to the
InnerVision Medical’s proprietary system architecture is derived from deep geologic seismic image processing techniques, which have been refined and conformed to medical ultrasound by the company’s team of engineers. When the system is paired with custom transducers, the technology is especially adept at deep tissue diagnostic imaging for obese patients. InnerVision believes its innovative technology has the capability to improve image quality for all patient body types.
The initial study of the InnerVision Medical prototype system is being conducted in accordance with the U.S. Food & Drug Administration’s (FDA) Investigational Device Exemption (IDE) under the approval of a local
About InnerVision Medical Technologies
InnerVision Medical was founded in 2002 with corporate headquarters in
For additional information, please visit http://www.innermed.com.
# # #
Read the full story at http://www.prweb.com/releases/InnervisionMedical/newultrasoundprototype/prweb11105161.htm
Most Popular Stories
- Slow Week Ahead of December FOMC Meeting
- Hispanics Seek to Grow School Board Members
- GM Bailout Saved 1.2 Million U.S. Jobs, Report Says
- Bitcoin Used to Buy Tesla Car
- U.S. Companies Eager for Iranian Business
- 'Knockout Game': Myth or Menace?
- Banks Fret as Volcker Vote Approaches
- Questions Remain in Jenni Rivera's Death
- Yellen Set to Become One of World's Most Powerful Women
- Paul Walker Fans Pay Respects